The mRNA encoding the mouse homolog of
ever, fat cells and intestinal cells contain 25-50% as much mRNA as liver cells. "Run-on" experiments show that the basis for the restricted cellular distribution of the mouse C/EBP mRNA is transcriptional regulation of the gene. We also show that disruption of cell-cell contacts incident to liver cell dispersion results in a prompt and extensive reduction in mouse C/EBP transcription as we had earlier shown to be the case for a group of 10 genes transcribed in a hepatocyte-specific fashion. In contrast, breaking cell contacts and plating the hepatocytes in culture leads to a prolonged increase in transcription of the Jun-B gene that encodes a widely distributed transcription factor. These results illustrate that the regulation of expression of a mammalian regulatory protein with limited tissue distribution is controlled at the level of transcription and depends on cell contacts.
We have previously shown that active transcription in hepatocyte nuclei, but not in brain, kidney, spleen, or cultured cell nuclei, was the basis for the presence in liver of an array of "liver-specific" mRNAs (1, 2) . We and many other laboratories have been engaged in identifying regulatory regions of the genes encoding these transcriptionally controlled mRNAs in order to study the proteins that bind to such regulatory regions (3) (4) (5) (6) (7) (8) . An important unanswered question about proteins that regulate hepatocyte-specific transcription is whether any such regulatory molecules will be limited in their cellular distribution perhaps only to hepatocytes. Alternatively, the important regulatory DNA-binding proteins may be present in all cells but active only in the liver because of a hepatocyte-specific modification.
In the past year it has become clear that extracts of hepatocytes, but not of several other cell types, contain at least four proteins (9) that can interact with DNA regions required for maximal transcription of transthyretin (TTR), a1-antitrypsin (al-AT), a-and P3-fibrinogen, albumin, and other genes expressed mainly in hepatocytes (4) (5) (6) (7) (8) . In addition, an alternative spliced mRNA encoding an NF-1-like DNA-binding protein, has a higher concentration in the liver than elsewhere (10) . Not all of these liver-enriched proteins bind to every gene expressed in hepatocytes, but in all cases the identified proteins bind to sites present in at least two different genes. Moreover, all of the tested genes so far require two or more proteins for maximal transcriptional activity. C/EBP, an enhancer-binding protein purified from rat liver by virtue of its affinity to viral enhancers (11) , is one of these proteins (12) . We mapped six sites in the TTR and al-AT enhancer and promoter regions that bound the same protein in liver extracts that was absent in brain, spleen, or kidney extracts (4, 9, 13) . In an artificial construct, multiple binding sites from the TTR gene can act as an enhancer for RNA synthesis from a reporter gene, indicating that the relevant protein is very likely a positive-acting transcription factor (13) . The liver protein could be highly purified by DNA-affinity chromatography using a TTR binding site (12) . Finally, these same sites in TTR and al-AT genes were also shown to bind C/EBP obtained as a fusion protein produced in bacteria from the cloned C/EBP cDNA (12, 14) . From these results it appeared to us that C/EBP was not widely distributed but was a transcription factor that is greatly enriched in liver compared with other cell types.
Here we report the isolation of the mouse homolog to (14) . Approximately 2.5 x 105 recombinant phages were screened by plaque hybridization under lowstringency conditions. Nitrocellulose filters were prehybridized in 35% formamide/5 x SSPE/0. 1% sodium dodecyl sulfate (SDS)/3 x Denhardt's solution/100 ,tg of denatured salmon sperm DNA per ml at 420C for 2-3 hr (1 x SSPE = 150 mM NaCl/10 mM NaH2PO4 H2O/1 mM Na2EDTA; Denhardt's solution = 0.02% bovine serum albumin/0.02% pyrrolidone/0.02% Ficoll). Hybridization was carried out overnight in the same solution with the addition of probe (_106 cpm/ml of hybridization solution). Washes were performed twice in 0.30 M NaCI/0.03 M sodium citrate, pH 7, containing 0.1% SDS at 58°C for 30 min. Positive clones were selected and purified after three rounds of hybridization, and the largest insert of the three overlapping positive clones was subcloned to a pGem-2 plasmid vector for further analysis. Different fragments of this cDNA insert were subcloned into the pGem-1, pGem-2, or pBluescript vectors and were sequenced by the chain-elongation method (15) .
Northern Blot Analysis and RNA in Situ Hybridizations. Total RNA was isolated from various tissues as described Abbreviations: al-AT, a1-antitrypsin; TTR, transthyretin; C/EBP, rat enhancer-binding protein; mC/EBP, mouse homolog of rat C/ EBP.
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Cell Biology: Xanthopoulos et al. (16) . Northern blot analysis of total RNA (25 ,ug per lane) was carried out by electrophoresis in 1% formaldehyde/agarose gel, transfer to nitrocellulose, and hybridization to appropriate DNA fragments labeled to a specific activity of 108 cpm/Ag by random priming (17) under high-stringency conditions. Prehybridization, hybridization, and washing of the nitrocellulose filters were performed by standard methods (18) . In situ hybridizations were performed as described (19) with an antisense 35S-labeled RNA prepared by in vitro transcription of an 800-base-pair (bp) mC/EBP cDNA fragment.
Isolation of Mouse Nuclei from Various Tissues and Nuclear Run-On Assays. Nuclei from different mouse tissues were isolated, and nuclear run-on assays were performed as described by hybridizing labeled nuclear RNA (1, 2, 20, 21) to an excess of different cDNAs immobilized (6 Ag per sample) on nitrocellulose filters and subjecting washed and RNasetreated filters to autoradiography (-70'C for 1-3 days with intensifying screens). Quantitation of the autoradiographic signal was carried out by densitometry (20) .
RESULTS
Cloning of mC/EBP cDNA. The C/EBP gene from rats was recently cloned (14) . With a sample of this clone (kindly provided by S. L. McKnight), we selected the mouse counterpart (mC/EBP) to the rat gene from a Agtll mouse liver cDNA library. As was reported for rat liver (14) , the mRNA was fairly scarce (3 clones out of 2.5 x 105 phage plaques).
Partial sequence analysis of the cDNA insert of this clone confirmed an open reading frame with almost complete amino acid sequence identity and 90-95% nucleic acid identity with the rat C/EBP in the protein coding region. (In the 159 amino acids encoded by the sequence that we have analyzed, a leucine replaces phenylalanine at position 82 of the rat sequence, an alanine at position 98 is deleted, and a leucine replaces methionine at position 237.) The gene encoding mC/EBP is about 2.7 kilobases (kb) long, single copy, and intronless (K.G.X. and J.E.D., Jr., unpublished results). In addition, by analysis of restriction fragment length polymorphisms in various strains of mice, we have assigned the gene to mouse chromosome 7 (22) .
Tissue Distribution of the mC/EBP mRNA. The relative steady-state concentrations of mC/EBP mRNA were determined by Northern blot analysis of total RNA from mouse brain, fat, kidney, liver, heart, and intestine tissues. Fat tissue was included because S. L. McKnight informed us that this tissue in rats contained C/EBP. The liver contained at least 50-fold more mC/EBP mRNA than did brain, spleen, or kidney tissue (Fig. 1A) . Long exposures of the film revealed faint bands in the kidney, heart, and spleen samples. Fat tissue contained about 50%, and small intestinal tissue contained about 25% as much mC/EBP mRNA as did the liver sample. A single mRNA band of similar size (-2.7 kb) was detected in all of these RNA samples. In the Northern experiments, the same amount of total RNA judged by UV absorption was added in each lane. After hybridization to mC/EBP, the filters were stripped and rehybridized with probes to mouse p-actin (top band of controls) and a mouse variant of a rat proteoglycan (bottom band of controls); the probe was selected by M. Salditt-Georgieff from a mouse liver cDNA library by using a rat proteoglycan clone kindly provided by E. Ruoslahti. These two mRNAs were present in all tissues, although the concentrations obviously varied.
Another test of the distribution of expression of mC/EBP mRNA in various cells is in situ hybridization. Nuclear Run-On Transcription Analysis. Nascent chain analysis of nuclear RNA synthesis, the so-called run-on transcription analysis, was used to determine the basis for the differential tissue distribution of mC/EBP mRNA. We first needed to determine whether transcription of a gene that yields rare mRNAs gave clear signals in these assays. Liver and kidney nuclei were used to prepare labeled nascent nuclear RNA (1, 20, 21) , and samples were hybridized to several cDNA clones, including albumin and mC/EBP cDNA ( Fig. 2A) . The mC/EBP transcriptional signal in the liver nuclei was very strong, -30% of that for albumin (the probe size was 2.2 kb for mC/EBP and 0.8 kb for albumin). In contrast, the kidney signal was barely above the background and was less than 5% that of the liver. The autoradiograms were scanned by densitometer and normalized to the tRNAMet signal, which was comparable in all samples. Since albumin mRNA represents about 1-2% of total liver mRNA (21) but has a transcriptional signal only about 2-3 times that of mC/EBP, whose mRNA is quite scarce, the mC/EBP transcript must have a relatively short half-life.
That the liver hybridization signal for mC/EBP was not a spurious one (for example, from a repetitive transcribed sequence) was indicated first by the fact that labeled kidney nuclear RNA gave little or no signal above background. In addition, genomic Southern blots using several restriction enzymes and mC/EBP cDNA as labeled probe showed (14) . Finally, a transcription experiment in which the cDNA was divided into three parts was carried out (Fig. 2B) . Each ofthe three segments ofthe cDNA gave an approximately equimolar signal, ruling out the presence of a localized repetitive sequence as the basis for the signal observed. Also this experiment detected no excessive 5'-end transcription that is characteristic of premature termination (24, 25) . To investigate further the cell specificity of transcription of the mC/EBP gene, additional experiments with nuclei from brain, fat, and spleen cells as well as kidney and liver were carried out (Fig. 2 B and C) . The transcriptional signal for mC/EBP was consistently strongest in the liver nuclei. Definite transcriptional signals were found also in fat and spleen nuclei but only low signals, just above background, in brain and kidney (Fig. 2 B and C and Table 1 ). By using either the input of total cpm or comparison with the signal for tRNAMet, it appears that mC/EBP is transcribed about 3040% as well in fat nuclei and 15% as well in spleen nuclei as it is in the liver. The transcription in total brain and kidney nuclei is no more than a few percent of that of liver.
In contrast to the large difference in mC/EBP transcription in different tissues, the gene for the widely distributed transcription factor Jun-B (23, 26) was transcribed at approximately similar rates in each of the tissues examined ( Fig. 2 B and C; Table 1 ).
The differential transcription shown in these experiments is sufficient to explain the presence of the mC/EBP mRNA in hepatocytes and its near absence in Northern blots of total brain, spleen, or kidney mRNA. This in turn correlates with our inability to extract from these tissues a protein that binds to oligonucleotides recognized by mC/EBP (4). The presence of about 50%o as much mRNA in fat cells as in liver cells was also reflected in the transcription rate in fat cells compared to hepatocytes. The very low but possibly real transcriptional signals in total brain tissue are in accord with the in situ hybridization results, which show the presence of mC/EBP mRNA in some brain cells.
Transcription Analysis in Cultured Primary Hepatocytes. When disaggregated hepatocytes are removed from animals and plated in culture as individual cells, the transcription rate ofgenes expressed in a liver-specific manner declines at least by a factor of 10 within the first 24 hr of culturing (20, 21) . We have determined the rate of mC/EBP transcription under these circumstances (Fig. 3 A and B) . Liver cells were dispersed by perfusion with EDTA and collagenase and were plated in culture for various periods. Nuclei were then collected to assay transcription from dispersed cells before and after culturing for various time periods. Albumin transcription was about 50% of the maximum level after 4 hr in culture and had decreased to about 10% after 24 hr in culture. The transcription rate of mC/EBP followed a pattern very similar to that of albumin. As we have pointed out in earlier work, this effect of cell dispersal on transcription by hepatocyte nuclei is not a general disruption of RNA polymerase II transcription but is specific to the differentiated hepatocyte profile (20, 21) . For example, the transcription rate of some other genes remains unaffected or, in the case of actin, Fig. 2 . Liver experiment A: the organs were removed and homogenized without perfusion as was the case for all other tissues. Liver experiment B: cells were isolated by perfusion of livers with collagenase before nuclei were preparea. temporarily rises and then declines 24 hr af culture (20, 21) . There is still a strong ac dispersed and cultured for 24 hr (Fig. 3 ). ments this signal had been shown to be ab( fresh liver nuclei (20, 21) .] In addition to as the transcription of the gene for the widely transcription factor in cultured hepatocytc the transcription of this gene is stimulated i cells by serum and that its transcription ra liver regeneration (23, 26) . There was a Jun-B transcription simply by perfusing th the cells (Fig. 2B, Fig. 3 (33) . Apolipoprotein C is transcribed in both liver and intestine (34) 
